semaglutide cv outcomes and cardiovascular in patients with type 2 diabetes SELECT: Glucagon-like peptide-1 receptor agonist obese disease in the absence of Semaglutide cardiovascular outcomes align more – Cardiovascular Outcomes, Safety, and Tolerability

Blood pressure may begin to decrease in hypertensive patients, and a small increase in heart rate is common

However, some providers might support use of GLP-1 medications during breastfeeding in specific situations, particularly if the mother has diabetes requiring management and other options are limited

#DiabetesCare #HealthyAging #MetabolicHealth #PreventiveMedicine #LifestyleMedicine #HealthcareInnovation #Douala #AfricaHealth #Cameroon #Cameroun To view or add a comment, sign in GLP-1 medications have transformed the conversation around diabetes and weight lossbut are you also thinking about long-term health

Semaglutide has more long-term safety data (approved since 2017 for diabetes)

Heavy, spicy foods: These can cause indigestion and heartburn, making it uncomfortable to lie down and fall asleep

Frequently Asked Questions There typically arent any serious side effects from a dose of glutathione IV